Journal Article DZNE-2025-00726

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Discrepancies in assessing intellectual disability levels in adults with Down syndrome: Implications for dementia diagnosis.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Wiley Hoboken, NJ

Alzheimer's and dementia 21(6), e70307 () [10.1002/alz.70307]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Cut-offs derived from baseline cognitive assessments, stratified by intellectual disability (ID) level, have been proposed to diagnose symptomatic Alzheimer's disease (AD) in Down syndrome (DS). However, discrepancies in ID classification risk misclassification when applying cut-offs across sites.This dual-center cohort study included 673 adults with mild to moderate ID at different AD stages. We assessed ID classification discrepancies across sites and the impact on Cambridge Cognitive Examination for Older Adults with Down's Syndrome (CAMCOG-DS) cut-offs for AD dementia diagnosis derived from receiver operating characteristic analysis.Inter-rater agreement for ID level classification was 95% within sites but 60% between sites. While CAMCOG-DS score distributions in the whole cohort were similar across sites, ID classification discrepancies caused higher cut-offs in Barcelona for mild and moderate ID compared to Munich. Applying site-specific cut-offs to another cohort reduced sensitivity and specificity.Standardizing ID classification is critical for generalizable cut-offs to accurately diagnose AD dementia based on neuropsychological assessments in DS.CAMCOG-DS cut-offs by intellectual disability level classify dementia in Down syndrome. ID classification discrepancies between sites impact CAMCOG-DS diagnostic cut-offs. Applying site-specific cut-offs to other cohorts reduces sensitivity and specificity. Standardized ID classification is essential for generalizable cognitive cut-offs. Use site-specific cut-offs until ID classification is standardized.

Keyword(s): Humans (MeSH) ; Down Syndrome: complications (MeSH) ; Intellectual Disability: diagnosis (MeSH) ; Female (MeSH) ; Male (MeSH) ; Neuropsychological Tests: statistics & numerical data (MeSH) ; Cohort Studies (MeSH) ; Middle Aged (MeSH) ; Aged (MeSH) ; Dementia: diagnosis (MeSH) ; Alzheimer Disease: diagnosis (MeSH) ; AD21 ; Alzheimer's disease ; Cambridge Cognitive Examination for Older Adults with Down Syndrome ; Down Alzheimer Barcelona Neuroimaging Initiative ; Down syndrome ; Down syndrome–associated Alzheimer's disease ; cut‐off points ; dementia ; diagnostic performance ; intellectual disability

Classification:

Contributing Institute(s):
  1. Clinical Research (Munich) (Clinical Research (Munich))
  2. Molecular Neurobiology (AG Simons)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)
  2. 351 - Brain Function (POF4-351) (POF4-351)

Appears in the scientific report 2025
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; OpenAccess ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Wiley ; Essential Science Indicators ; IF >= 10 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > M DZNE > M DZNE-Clinical Research (Munich)
Document types > Articles > Journal Article
Institute Collections > M DZNE > M DZNE-AG Simons
Full Text Collection
Public records
Publications Database

 Record created 2025-07-01, last modified 2025-07-13